Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study

Abstract Hepatocellular carcinoma (HCC) comprises 75 to 85% of all primary liver cancers. Current guidelines recommend a biannual HCC surveillance using ultrasound (US) for high-risk patients. However, due to its low sensitivity for detection of early-stage HCC lesions, there is an urgency for more...

Full description

Bibliographic Details
Main Authors: Céline van de Braak, François E. J. A. Willemssen, Rob A. de Man, Aad van der Lugt, Carin A. Uyl-de Groot, Daniel Bos, Roy S. Dwarkasing
Format: Article
Language:English
Published: SpringerOpen 2024-03-01
Series:European Radiology Experimental
Subjects:
Online Access:https://doi.org/10.1186/s41747-024-00432-6
_version_ 1797259506559746048
author Céline van de Braak
François E. J. A. Willemssen
Rob A. de Man
Aad van der Lugt
Carin A. Uyl-de Groot
Daniel Bos
Roy S. Dwarkasing
author_facet Céline van de Braak
François E. J. A. Willemssen
Rob A. de Man
Aad van der Lugt
Carin A. Uyl-de Groot
Daniel Bos
Roy S. Dwarkasing
author_sort Céline van de Braak
collection DOAJ
description Abstract Hepatocellular carcinoma (HCC) comprises 75 to 85% of all primary liver cancers. Current guidelines recommend a biannual HCC surveillance using ultrasound (US) for high-risk patients. However, due to its low sensitivity for detection of early-stage HCC lesions, there is an urgency for more sensitive surveillance tools. Here, we describe the potential of a short MRI surveillance (SMS) protocol for HCC, including axial T1-weighted in-out phase, fat-saturated T2-weighted, and diffusion-weighted sequences. In this prospective, multicenter, patient cohort study, patients will be recruited from existing HCC surveillance cohorts of six medical centers in The Netherlands. Surveillance patients who undergo biannual US, will be invited for SMS on the same day for 3 years. In case of a suspicious finding on either US or SMS, patients will be invited for a full MRI liver protocol including gadolinium-based contrast agent intravenous injection within 2 weeks. To our knowledge, this will be the first study to perform a head-to-head comparison with a paired US-MRI design. We hypothesize that the sensitivity of SMS for detection of early-stage HCC will be higher than that of US leading to improved survival of surveillance patients through timely HCC diagnosis. Furthermore, we hypothesize that the SMS-HCC protocol will prove cost-effective. Relevance statement The US sensitivity for detecting early-stage HCC has been reported to be less than 50%. We expect that the proposed SMS will detect at least twice as many early-stage HCC lesions and therefore prove to be cost-effective. Key points • The low sensitivity of US necessitates better imaging tools for HCC screening. • This is the first study with a paired US-MRI design. • This design will allow a head-to-head comparison in both diagnostics and patient-acceptance. • We expect that SMS can contribute to a higher survival rate. Graphical Abstract
first_indexed 2024-04-24T23:10:31Z
format Article
id doaj.art-748fc83f9deb456d9dfe231f52fc62a8
institution Directory Open Access Journal
issn 2509-9280
language English
last_indexed 2024-04-24T23:10:31Z
publishDate 2024-03-01
publisher SpringerOpen
record_format Article
series European Radiology Experimental
spelling doaj.art-748fc83f9deb456d9dfe231f52fc62a82024-03-17T12:14:02ZengSpringerOpenEuropean Radiology Experimental2509-92802024-03-01811810.1186/s41747-024-00432-6Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter studyCéline van de Braak0François E. J. A. Willemssen1Rob A. de Man2Aad van der Lugt3Carin A. Uyl-de Groot4Daniel Bos5Roy S. Dwarkasing6Department of Radiology & Nuclear Medicine, Erasmus Medical CenterDepartment of Radiology & Nuclear Medicine, Erasmus Medical CenterDepartment of Hepatology, Erasmus Medical CenterDepartment of Radiology & Nuclear Medicine, Erasmus Medical CenterErasmus School of Health Policy & Management and Institute for Medical Technology Assessment, Erasmus University RotterdamDepartment of Radiology & Nuclear Medicine, Erasmus Medical CenterDepartment of Radiology & Nuclear Medicine, Erasmus Medical CenterAbstract Hepatocellular carcinoma (HCC) comprises 75 to 85% of all primary liver cancers. Current guidelines recommend a biannual HCC surveillance using ultrasound (US) for high-risk patients. However, due to its low sensitivity for detection of early-stage HCC lesions, there is an urgency for more sensitive surveillance tools. Here, we describe the potential of a short MRI surveillance (SMS) protocol for HCC, including axial T1-weighted in-out phase, fat-saturated T2-weighted, and diffusion-weighted sequences. In this prospective, multicenter, patient cohort study, patients will be recruited from existing HCC surveillance cohorts of six medical centers in The Netherlands. Surveillance patients who undergo biannual US, will be invited for SMS on the same day for 3 years. In case of a suspicious finding on either US or SMS, patients will be invited for a full MRI liver protocol including gadolinium-based contrast agent intravenous injection within 2 weeks. To our knowledge, this will be the first study to perform a head-to-head comparison with a paired US-MRI design. We hypothesize that the sensitivity of SMS for detection of early-stage HCC will be higher than that of US leading to improved survival of surveillance patients through timely HCC diagnosis. Furthermore, we hypothesize that the SMS-HCC protocol will prove cost-effective. Relevance statement The US sensitivity for detecting early-stage HCC has been reported to be less than 50%. We expect that the proposed SMS will detect at least twice as many early-stage HCC lesions and therefore prove to be cost-effective. Key points • The low sensitivity of US necessitates better imaging tools for HCC screening. • This is the first study with a paired US-MRI design. • This design will allow a head-to-head comparison in both diagnostics and patient-acceptance. • We expect that SMS can contribute to a higher survival rate. Graphical Abstracthttps://doi.org/10.1186/s41747-024-00432-6HepatitisHepatocellular carcinomaLiver cirrhosisMagnetic resonance imagingUltrasonography
spellingShingle Céline van de Braak
François E. J. A. Willemssen
Rob A. de Man
Aad van der Lugt
Carin A. Uyl-de Groot
Daniel Bos
Roy S. Dwarkasing
Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study
European Radiology Experimental
Hepatitis
Hepatocellular carcinoma
Liver cirrhosis
Magnetic resonance imaging
Ultrasonography
title Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study
title_full Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study
title_fullStr Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study
title_full_unstemmed Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study
title_short Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study
title_sort non contrast short mri surveillance for hcc screening the study protocol of the sms hcc prospective multicenter study
topic Hepatitis
Hepatocellular carcinoma
Liver cirrhosis
Magnetic resonance imaging
Ultrasonography
url https://doi.org/10.1186/s41747-024-00432-6
work_keys_str_mv AT celinevandebraak noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy
AT francoisejawillemssen noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy
AT robademan noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy
AT aadvanderlugt noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy
AT carinauyldegroot noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy
AT danielbos noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy
AT roysdwarkasing noncontrastshortmrisurveillanceforhccscreeningthestudyprotocolofthesmshccprospectivemulticenterstudy